Women with persistent antiphospholipid antibodies who are planning pregnancy research hub

HYPATIA: A prospective randomised controlled trial of hydroxychloroquine to improve pregnancy outcome in women with antiphospholipid antibodies

This trial looks at whether a tablet called hydroxychloroquine can help women with antiphospholipid antibodies have safer, healthier pregnancies. These antibodies increase the risk of blood clots and miscarriage. Women planning a pregnancy will take either the study medicine or a dummy tablet alongside their usual care until giving birth.